drugset / Trial / NCT01275365

Optimizing Protein Intake in Older Americans With Mobility Limitations

NCT01275365

RandomizedFactorialQuadruple-blindTreatment

Summary

This will be a randomized, placebo-controlled, parallel group, double blind, clinical trial in community dwelling, older men, 65 years of age or older, who have mobility limitation and low protein intake. The study will have a 2 X 2 factorial design, which will allow us to investigate the effects of dietary protein intake and testosterone separately and together.

Timeline

Start
2011-05
Primary completion
2017-01-19
Completion
2017-01-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Enanthate Small molecule 100 mg Intramuscular

Indications

No indication recorded.